As a new investor I am at a loss to know why this little gem never goes anywhere

Is is a medical company with no debt, a profit!, minimal market capital and some interesting products.

We're in the shares4 schools contest and we'd like this babe to fly!

Is it today?

It was yesterday and the information flow was very good.

Any thoughts?

The usual tick back following solid news,the Independent said today that SI boasts of continuing progress in all areas of its business, so we await a little longer for our re-rating.The mms stance on the spread will prevent smaller buyers for the time being but this I feel will finally change.ie larger investor,some director buys and a forthcoming press tip.The projected sales market for the Variglide product around 1/2bn with further contracts on the way speaks for itself,looking forward to the next tieup which was mentioned in a few days time at the AGM.

It's a long slog!

Keep applying the factor 30 while we wait?

Will Friday's buyer turn up today -We need a believer!

Nothing is going to move it I think until the mms are ready,perhaps the promised worldwide distribution deal to be announced shortly will do the trick?

It's about to bounce. The gap has narrowed and the buyers are arriving. It may not be much but who knows?

Yes just logged on surprising to see the number of buys after the mark down earlier today.Volume nearing 2m with a couple of nice buys thrown in,(our Friday buyer perhaps)talk of the world distribution deal also in the background nice to see a bit of interest today,practice for the real action to come.

charts are negative.this should be trading at under 1p in a few weeks

Some Director involvement this week prior to news of the worldwide sales agreement?

Todays Independent 1.11.O4
Surgical Innoations is being circled by brokers keen to snatch the company away from its current adviser,Westhouse.
A new broker it says could bring acquisition opportunities to the company, then SI shares could be worth watching.

Looks like the sun will shine now with news yesterday - deal with Rolls Royce.
Any one any comment!!! p/271

Yes it did!

Hurray!

Yes it did!

Nice one!

An interesting few days ahead of us..........Results next week should be fine and given the bumper start to the new year the share should move up. They're dancing around the year low is 50% possible in 10 days?

Fingers crossed.

Preliminary Results

Financial highlights
· Revenue of £7.64m (2011: £7.60m)
§ SI branded sales up 12.9% to £5.33m (2011: £4.73m) - representing 68% of total revenue
· Gross profit up 7.3% to £3.86m (2011: £3.60m)
· Gross margins improved to 50.5% (2011: 47.3%)
· Adjusted EBITDA (excluding exceptional items) of £2.89m (2011: £2.83m)
· Operating profit reduced to £1.32m (2011: £1.77m) - due to amortisation and exceptional costs
· Pre-tax profit reduced to £1.23m (2011: £1.71m)
· Adjusted earnings per share of 0.35p (2011: 0.44p)
· Net cash from operating activities of £612,000 (2011: £1.78m) - reflecting increase in working capital as a result of significant sales in December 2012

Operational highlights
· Strong second half sales with contracted orders in H2 of £5.62m up 85% on H1 (with c. £1m to be recognised in y/e 31 December 2013)
· US direct sales up 21.9% to £2.15m (2011: £1.76m) and are now 28.1% of total revenue (2011: 23.2%)
· 33% increase in unit sales of YelloPort+plus™ valves and swingtops
· YelloPort+plus™ cannula sales increased to 10,124 units (2011: 5,272 units) - will drive long term valve sales
· RGF grant of up to £5.05m to fund capital expansion strategy
· FDA approvals and US contracts provide a solid base for development of US strategy
· UK SI branded sales up 34.3% as more NHS hospitals convert to cost-saving Resposable® products
· New areas of MIS progressing well, particularly ultra-MIS (3mm) and hip arthroscopy

Surgical Innovations Group - Preliminary results

Audio Webcast

Senior Appointment of President of US Sales and Operations